Skip to main content
. 2019 Mar 19;11:177–190. doi: 10.2147/IJWH.S160022

Table 5.

Process and outcome indicators related to specific conditions

n (%)
Prevention of postpartum hemorrhage
 Target population: women giving birth in health care facilities 1,001
 Oxytocin use 79.5
 Use of any uterotonic (including oxytocin) 29.7
Treatment of severe postpartum hemorrhage
 Target population: women with severe postpartum hemorrhage 46
 Oxytocin use 39 (84.8)
 Ergometrine 0
 Misoprostol 11 (10.6)
 Any of the above uterotonics 39 (84.6)
 Tranexamic acid 0
 Removal of retained products 1 (0.96)
 Balloon or condom tamponade 1 (0.96)
 Artery ligation 0
 Hysterectomy 12 (11.5)
 Abdominal packing 0
Anticonvulsants for eclampsia
 Target population: women with eclampsia 19
 Magnesium sulfate 16 (84.2)
 Other anticonvulsant 0
 Any anticonvulsant 16 (84.2)
Prevention of cesarean section-related infection
 Target population: women undergoing cesarean section 45
 Prophylactic antibiotic during cesarean section 39 (86.7)
Treatment for sepsis
 Target population: women with sepsis 18
 Parenteral therapeutic antibiotics 15 (83.3)
Ruptured uterus
 Target population: women with ruptured uteri 9
 Laparotomy 8 (88.9)
 Laparotomy after 3 hours of hospital stay 3 (33.3)
Preterm birth
 Target population: women having a preterm delivery 22
 Corticosteroids for fetal lung maturation 8 (36.4)